SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

Not all strokes are equally devastating, and new research shows that certain health risks don’t just increase your chances of ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

The Board of Directors of Carlisle Companies Incorporated today elected James D. Frias as Lead Independent Director succeeding Robin J. Adams, who previously held the position. Mr. Adams will retire ...

“It was an experience that dramatically improved my life,” said Mike Prescott of Kenosha, who retired a couple of years ago ...

A cardiologist has shared six warning signs of heart troubles that should never be ignored after TV presenter Emma Willis, 49 ...

When it comes to a simple, accessible, beneficial form of exercise, walking is hard to top – and a new study suggests that ...

System1, Inc. ("System1" or the "Company"), an omnichannel customer acquisition marketing platform, announced today that it will report financial results for the first quarter ended March 31, 2025 on ...

Oral semaglutide (Rybelsus) can be tied to a near halving of incident Afib, according to a meta-analysis of 26 randomized ...

Here’s a reason to celebrate: new research suggests this boozy beverage can have protective benefits to your heart.

Researchers sought to determine the relationship among hospitalization for COPD exacerbation, AF burden, and risk for subsequent stroke.